Literature DB >> 15839850

Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods.

R Taffi1, A Vignini, C Lanciotti, R Luconi, L Nanetti, L Mazzanti, L Provinciali, M Silvestrini, M Bartolini.   

Abstract

Previous investigations have suggested that changes in platelet activity may play a key role in the pathophysiology of migraine via mechanisms involving the nitric oxide (NO) pathway. Changes in platelet response and nitrite levels have recently been demonstrated during migraine attacks, while there is considerable uncertainty about NO activity in headache-free periods. A reactive oxidant produced from NO and superoxide anion at the site of inflammation, peroxynitrite (ONOO-) has effects including changes in membrane activity and fluidity. The aim of the present study was to determine ONOO- levels in the platelets of patients suffering from migraine during the headache-free period. Nitric oxide synthase (eNOS and iNOS) expression in platelets and the effects of ONOO- on membrane Na+/K+-ATPase activity and membrane fluidity were also evaluated. Subjects were 57 patients suffering from migraine without aura and 35 controls. Blood samples were collected in the headache-free period. Platelet ONOO- levels were determined using dichlorofluorescein acetate with steady-state fluorescence. Platelets were then probed for induction of eNOS and iNOS expression by western immunoblotting. Membrane Na+/K+-ATPase activity and fluidity were determined with the fluorescent probes TMA-DPH and DPH. In the presence of extracellular l-arginine(100 micromol/l), ONOO- production was significantly greater in patients' platelets than in those of controls (P < 0.001). Western immunoblotting of platelet proteins evidenced higher iNOS expression in patients than in controls. In addition, platelet membrane Na+/K+-ATPase activity and membrane fluidity evaluated by TMA-DPH were significantly lower in patients (P < 0.001). In conclusion, migraine patients show intercritic changes in platelet membrane fluidity and activity that may be related to the oxidative stress caused by increased ONOO- levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15839850     DOI: 10.1111/j.1468-2982.2004.00863.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  10 in total

Review 1.  Emerging Treatment Targets for Migraine and Other Headaches.

Authors:  Zachariah Bertels; Amynah Amir Ali Pradhan
Journal:  Headache       Date:  2019-07       Impact factor: 5.887

Review 2.  Targeted Nitric Oxide Synthase Inhibitors for Migraine.

Authors:  Amynah A Pradhan; Zachariah Bertels; Simon Akerman
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

3.  Paraoxonase 1 (PON1) polymorphisms and risk for migraine.

Authors:  Elena García-Martín; Carmen Martínez; Mercedes Serrador; Hortensia Alonso-Navarro; Francisco Navacerrada; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  J Neurol       Date:  2010-04-21       Impact factor: 4.849

Review 4.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

5.  Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group.

Authors:  Ravi Gupta; Rahul Pathak; Manjeet Singh Bhatia; Basu Deb Banerjee
Journal:  Ann Indian Acad Neurol       Date:  2009-07       Impact factor: 1.383

6.  Peroxynitrite affects lidocaine by acting on membrane-constituting lipids.

Authors:  Takahiro Ueno; Maki Mizogami; Ko Takakura; Hironori Tsuchiya
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

7.  Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine.

Authors:  Ertugrul Uzar; Osman Evliyaoglu; Gülten Toprak; Abdullah Acar; Yavuz Yucel; Tugba Calisir; Mehmet Ugur Cevik; Nebahat Tasdemir
Journal:  J Headache Pain       Date:  2011-02-27       Impact factor: 7.277

Review 8.  Genetic and biochemical changes of the serotonergic system in migraine pathobiology.

Authors:  Claudia Francesca Gasparini; Robert Anthony Smith; Lyn Robyn Griffiths
Journal:  J Headache Pain       Date:  2017-02-13       Impact factor: 7.277

9.  Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica.

Authors:  Ju-Yang Jung; Eunyoung Lee; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  J Clin Lab Anal       Date:  2019-08-11       Impact factor: 2.352

Review 10.  New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?

Authors:  Claudio Tana; Emmanuele Tafuri; Marco Tana; Paolo Martelletti; Andrea Negro; Giannapia Affaitati; Alessandra Fabrizio; Raffaele Costantini; Andrea Mezzetti; Maria Adele Giamberardino
Journal:  J Headache Pain       Date:  2013-02-01       Impact factor: 7.277

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.